Kymera Therapeutics Inc. (KYMR)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
44.42
0.29 (0.66%)
At close: Jan 23, 2025, 1:32 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Revenue | 78.59M | 46.83M | 72.83M | 34.03M | 2.93M | n/a |
Cost of Revenue | 189.08M | 2.98M | 2.40M | 62.10M | 825.00K | 205.00K |
Gross Profit | -110.49M | 43.85M | 70.44M | -28.07M | 2.11M | -205.00K |
Operating Income | -165.53M | -161.26M | -100.53M | -46.30M | -42.20M | -21.45M |
Interest Income | 18.76M | 6.62M | 488.00K | 826.00K | 1.00M | n/a |
Pretax Income | -146.96M | -154.81M | -100.22M | -45.59M | -41.25M | -21.47M |
Net Income | -146.96M | -151.83M | -98.00M | -43.95M | -41.29M | -21.47M |
Selling & General & Admin | 55.04M | 43.83M | 36.34M | 18.23M | 7.98M | 3.77M |
Research & Development | 189.08M | 164.25M | 137.02M | 62.10M | 37.16M | 17.68M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 244.12M | 208.08M | 173.36M | 80.34M | 45.14M | 21.45M |
Interest Expense | 196.00K | 176.00K | 175.00K | 115.00K | 46.00K | 16.00K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 244.12M | 208.08M | 173.36M | 80.34M | 45.14M | 21.45M |
Income Tax | n/a | -2.98M | -2.22M | -1.65M | 46.00K | 43.86K |
Shares Outstanding (Basic) | 58.37M | 53.93M | 47.99M | 17.35M | 44.53M | 44.53M |
Shares Outstanding (Diluted) | 58.37M | 53.93M | 47.99M | 17.35M | 44.53M | 44.53M |
EPS (Basic) | -2.52 | -2.82 | -2.04 | -2.53 | -0.93 | -0.48 |
EPS (Diluted) | -2.52 | -2.82 | -2.04 | -2.53 | -0.93 | -0.48 |
EBITDA | -143.20M | -151.66M | -97.64M | -43.72M | -40.38M | -21.25M |
Depreciation & Amortization | 3.56M | 2.98M | 2.40M | 1.76M | 825.00K | 205.00K |